Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids
Conclusions:
Awareness of the hazards of drug use during pregnancy should be improved to encourage health care providers to urge pregnant women to abstain from cannabis and, if cannabis-dependent, seek treatment. Moreover, substances used throughout pregnancy should be monitored as a deterrent to cannabis use, and potential cannabis-dependent women should be identified, so as to limit cannabis-fetal exposure during gestation, and provided appropriate treatment.
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Focus Series: Therapeutic Drug Monitoring During Pregnancy and Lactation Source Type: research
More News: Brain | Drugs & Pharmacology | Health Management | Milk | Miscarriage | Neurology | OBGYN | Perinatology & Neonatology | Pregnancy | Study | Women